CTIC

CTI BioPharma Corp. (DE) Common Stock

Delisted

CTIC was delisted on the 23rd of June, 2023.

38 hedge funds and large institutions have $85.1M invested in CTI BioPharma Corp. (DE) Common Stock in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-5
Holders Change %
-11.63%
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
5
Increased
10
Reduced
8
Closed
10
Calls
$541K
Puts
$122K
Net Calls
+$419K
Net Calls Change
+$385K
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$9K +$4.92K +2,330 +121%
Osaic Holdings
27
Osaic Holdings
Arizona
$2K
Barclays
28
Barclays
United Kingdom
$1K -$1.7K -880 -63%
Wells Fargo
29
Wells Fargo
California
$1K -$747 -260 -43%
GEA
30
Glen Eagle Advisors
New Jersey
$538
Millennium Management
31
Millennium Management
New York
-$71K -60,798 Closed
PP
32
Paloma Partners
Connecticut
-$35K -30,289 Closed
HF
33
HRT Financial
New York
-$22K -19,710 Closed
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
-$15K -13,207 Closed
WS
35
Wedbush Securities
California
-$15K -12,600 Closed
Creative Planning
36
Creative Planning
Kansas
-$15K -12,573 Closed
CLOS
37
Compagnie Lombard Odier SCmA
Switzerland
-$1K -800 Closed
Federated Hermes
38
Federated Hermes
Pennsylvania
-$1K -209 Closed